Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developing mRNA Nanomedicines with Advanced Targeting Functions. | Nanomicro Lett | 2025 | 39979495 | PubTator, text mining | PubMed |
| Intrahepatic Cholestasis of Pregnancy: A Single-Centre Whole-Exome Sequencing Study in a Maltese Cohort. | Clin Genet | 2025 | 39956944 | PubTator, text mining | PubMed |
| Mechanisms of resistance against allylamine and azole antifungals in Trichophyton: A renewed call for innovative molecular diagnostics in susceptibility testing. | PLoS Pathog | 2025 | 39932950 | PubTator, text mining | PubMed |
| Network pharmacology and in silico approach to study the mechanism of quercetin against breast cancer. | In Silico Pharmacol | 2025 | 39925462 | PubTator, text mining | PubMed |
| Why do microplastics aggravate cholestatic liver disease? The NLRP3-mediated intestinal barrier integrity damage matter. | Environ Pollut | 2025 | 39870129 | PubTator, text mining | PubMed |
| Edaravone is a Therapeutic Candidate for Doxorubicin-Induced Cardiomyopathy by Activating the Nrf2 Pathway. | Pharmacol Res Perspect | 2025 | 39865410 | PubTator, text mining | PubMed |
| Association between ABCB4 variants and intrahepatic cholestasis of pregnancy. | Sci Rep | 2025 | 39865141 | PubTator, text mining | PubMed |
| Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- Mice. | Liver Int | 2025 | 39804015 | PubTator, text mining | PubMed |
| A family with gallstone disease: defining inherited risk in the era of clinical genetic testing. | Intern Emerg Med | 2025 | 39786488 | PubTator, text mining | PubMed |
| Current approach to diagnosis and management of low-phospholipid associated cholelithiasis syndrome. | Curr Opin Gastroenterol | 2025 | 39782681 | PubTator, text mining | PubMed |
| "Shared genes, different clinical challenges: A new likely pathogenic variant in the ABCB4 gene". | Clin Res Hepatol Gastroenterol | 2025 | 39515607 | PubTator, text mining | PubMed |
| Expanding the spectrum of progressive familial intrahepatic cholestasis: A report of 3 cases. | Am J Clin Pathol | 2025 | 39333837 | PubTator, text mining | PubMed |
| Pediatric gallstone disease-Management difficulties in clinical practice. | Gastroenterol Hepatol | 2025 | 38986841 | PubTator, text mining | PubMed |
| A Case of Progressive Familial Intrahepatic Cholestasis Type-3. | Cureus | 2024 | 39618628 | PubTator, text mining | PubMed |
| A novel genetic variant associated with progressive familial intrahepatic cholestasis type 3: A case series. | JPGN Rep | 2024 | 39610430 | PubTator, text mining | PubMed |
| [Study on the mechanism of Fuzheng Huayu formula against biliary fibrosis in mice]. | Zhonghua Gan Zang Bing Za Zhi | 2024 | 39606971 | PubTator, text mining | PubMed |
Trichophyton indotineae Erg1Ala448Thr Strain Expressed Constitutively High Levels of Sterol 14-α Demethylase Erg11B mRNA, While Transporter MDR3 and Erg11A mRNA Expression Was Induced After Addition of Short Chain Azoles. | J Fungi (Basel) | 2024 | 39590650 | PubTator, text mining | PubMed |
| [Clinical characteristics of ABCB4 gene variant-associated cholestatic liver disease in adults]. | Zhonghua Gan Zang Bing Za Zhi | 2024 | 39528329 | PubTator, text mining | PubMed |
| Identification of novel ABCB4 variants and genotype-phenotype correlation in progressive familial intrahepatic cholestasis type 3. | Sci Rep | 2024 | 39521930 | PubTator, text mining | PubMed |
| Serum metabonomics reveal the effectiveness of human placental mesenchymal stem cell therapy for primary sclerosing cholangitis. | Stem Cell Res Ther | 2024 | 39380092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=6